Company Filing History:
1 out of 29 
1 out of 505 
Years Active: 2012-2022
Title: The Innovations of Motti Erlich
Introduction
Motti Erlich, an accomplished inventor based in Petach Tikva, Israel, has significantly contributed to the field of pharmaceuticals through his innovative patents. With a total of two patents to his name, Erlich's work focuses on formulations that enhance the efficacy and application of vital medications.
Latest Patents
Motti Erlich's latest patents exhibit his expertise in pharmaceutical chemistry. One of his notable patents includes "Solid State Forms of Valbenazine," which discloses various solid state forms of Valbenazine, alongside its salts, methods for preparation, and pharmaceutical compositions. This invention is pivotal for improving the delivery and stability of the medication.
Another significant invention by Erlich is the patent for "Solid State Forms of Sitagliptin Salts." This patent provides crystalline forms of Sitagliptin salts, along with processes for their preparation and associated pharmaceutical compositions. These advancements are critical in the treatment of conditions such as diabetes, showcasing Erlich's dedication to improving patient outcomes through innovative drug formulations.
Career Highlights
Throughout his career, Motti Erlich has worked with several prominent companies, including Assia Chemical Industries Ltd. and Teva Pharmaceutical Industries Limited. His experiences at these reputable organizations have undoubtedly shaped his approach to pharmaceutical development and innovation.
Collaborations
Motti Erlich has also collaborated with talented coworkers, such as Ariel Mittelman and Sharona Shachan-Tov. These partnerships have allowed for a creative exchange of ideas and expertise, further enriching the quality of his inventions.
Conclusion
In conclusion, Motti Erlich stands out as an influential inventor in the pharmaceutical industry. His patents not only highlight his innovative spirit but also contribute significantly to advancements in medication formulation. With a commitment to enhancing medical therapies, Erlich's work continues to have a meaningful impact on patient care and treatment efficacy.